6,157
Views
42
CrossRef citations to date
0
Altmetric
Review Articles

Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective

, MScPharm, PhD
Article: 24555 | Received 06 Apr 2014, Accepted 06 Sep 2014, Published online: 01 Oct 2014

References

  • Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18: 657–86. [PubMed Abstract] [PubMed CentralFull Text].
  • Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, etal. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother. 2009; 63: 1–4. [PubMed Abstract] [PubMed CentralFull Text].
  • Birkett CI, Ludlam HA, Woodford N, Brown DF, Brown NM, Roberts MT, etal. Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases. J Med Microbiol. 2007; 56: 52–5. [PubMed Abstract].
  • D'Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol. 2013; 303: 305–17. [PubMed Abstract].
  • Abraham S, Chapman TA, Zhang R, Chin J, Mabbett AN, Totsika M, etal. Molecular characterization of Escherichia coli strains that cause symptomatic and asymptomatic urinary tract infections. J Clin Microbiol. 2012; 50: 1027–30. [PubMed Abstract] [PubMed CentralFull Text].
  • Madigan MT, Martinko JM, Parker J. Brock biology of microorganisms. 2003; NJ, USA: Pearson Education, Inc., Upper Saddle iver. 10th ed.
  • Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Wisell KT, etal. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007–2011. Clin Microbiol Infect. 2014; 20: O344–52. [PubMed Abstract].
  • de Kraker ME, Davey PG, Grundmann H. BURDEN study group Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011; 8: 1001104.
  • Giske CG, Monnet DL, Cars O, Carmeli Y ReAct-Action on Antibiotic Resistance Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008; 52: 813–21. [PubMed Abstract] [PubMed CentralFull Text].
  • Peralta G, Lamelo M, Alvarez-Garcia P, Velasco M, Delgado A, Horcajada JP, etal. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012; 12: 245. [PubMed Abstract] [PubMed CentralFull Text].
  • Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004; 48: 1–14. [PubMed Abstract] [PubMed CentralFull Text].
  • Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol. 2006; 9: 466–75. [PubMed Abstract].
  • Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, etal. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS. 2009; 117: 526–36. [PubMed Abstract].
  • Olesen B, Hansen DS, Nilsson F, Frimodt-Moller J, Leihof RF, Struve C, etal. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol. 2013; 51: 1779–85. [PubMed Abstract] [PubMed CentralFull Text].
  • Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, etal. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect. 2010; 16: 1158–61. [PubMed Abstract].
  • Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J, Resistance TF. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004. Scand J Infect Dis. 2007; 39: 417–24. [PubMed Abstract].
  • Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M. Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother. 2002; 46: 151–9. [PubMed Abstract] [PubMed CentralFull Text].
  • Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, etal. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007; 59: 165–74. [PubMed Abstract].
  • Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist. 2011; 17: 83–97. [PubMed Abstract].
  • Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, etal. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013; 56: 641–8. [PubMed Abstract] [PubMed CentralFull Text].
  • Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, etal. Community spread of extended-spectrum beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. J Med Microbiol. 2013; 62: 1038–43. [PubMed Abstract].
  • Xia S, Fan X, Huang Z, Xia L, Xiao M, Chen R, etal. Dominance of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One. 2014; 9: e100707. [PubMed Abstract] [PubMed CentralFull Text].
  • Muzaheed, Doi Y, Adams-Haduch JM, Endimiani A, Sidjabat HE, Gaddad SM, etal. High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother. 2008; 61: 1393–4. [PubMed Abstract] [PubMed CentralFull Text].
  • Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol. 2008; 153: S347–57. [PubMed Abstract] [PubMed CentralFull Text].
  • Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014; 27: 543–74. [PubMed Abstract].
  • Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Tegmark Wisell K. Epidemiology of ESBL-producing Escherichia coli in Sweden 2007–2011. Clin Microbiol Infect. 2013; 20(6): O344–52.
  • Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini AL. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol. 2014; 52: 2530–5. [PubMed Abstract].
  • Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS. 2008; 116: 302–8. [PubMed Abstract].
  • Rettedal S, Lohr IH, Natas O, Giske CG, Sundsfjord A, Oymar K. First outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting. APMIS. 2012; 120: 612–21. [PubMed Abstract].
  • Novick RP. Plasmid incompatibility. Microbiol Rev. 1987; 51: 381–95. [PubMed Abstract] [PubMed CentralFull Text].
  • Couturier M, Bex F, Bergquist PL, Maas WK. Identification and classification of bacterial plasmids. Microbiol Rev. 1988; 52: 375–95. [PubMed Abstract] [PubMed CentralFull Text].
  • Carattoli A. Plasmids in Gram negatives: molecular typing of resistance plasmids. Int J Med Microbiol. 2011; 301: 654–8. [PubMed Abstract].
  • Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol. 2013; 303: 298–304. [PubMed Abstract].
  • Brolund A, Franzen O, Melefors O, Tegmark-Wisell K, Sandegren L. Plasmidome-analysis of ESBL-producing Escherichia coli using conventional typing and high-throughput sequencing. PLoS One. 2013; 8: e65793. [PubMed Abstract] [PubMed CentralFull Text].
  • Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010; 65: 2518–29. [PubMed Abstract].
  • Bengtsson S, Naseer U, Sundsfjord A, Kahlmeter G, Sundqvist M. Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother. 2012; 67: 69–73. [PubMed Abstract].
  • Helldal L, Karami N, Floren K, Welinder-Olsson C, Moore ER, Ahren C. Shift of CTX-M genotypes has determined the increased prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in south-western Sweden. Clin Microbiol Infect. 2013; 19: E87–90. [PubMed Abstract].
  • Ostholm-Balkhed A, Tarnberg M, Nilsson M, Johansson AV, Hanberger H, Monstein HJ, etal. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden. Scand J Infect Dis. 2010; 42: 831–8. [PubMed Abstract].
  • Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011; 30: 1159–62. [PubMed Abstract].
  • Kaarme J, Molin Y, Olsen B, Melhus A. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr. 2013; 102: 655–60. [PubMed Abstract].
  • Hansen F, Olsen SS, Heltberg O, Justesen US, Fuglsang-Damgaard D, Knudsen JD, etal. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Microb Drug Resist. 2014; 20: 316–24. [PubMed Abstract].
  • NORM/NORM-VET 2012. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. 2013. Tromsø/Oslo.
  • Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother. 2013; 57: 3012–20. [PubMed Abstract] [PubMed CentralFull Text].
  • Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, etal. Prevalence and characterization of extended-spectrum beta-lactamase- and AmpC beta-lactamase-producing Escherichia coli: results of the CANWARD 2007–2009 study. Diagn Microbiol Infect Dis. 2011; 69: 326–34. [PubMed Abstract].
  • Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010; 23: 320–6. [PubMed Abstract].
  • Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist. 2012; 5: 65–73. [PubMed Abstract] [PubMed CentralFull Text].
  • SWEDRES-SVARM. Use of antimicrobials and occurrence of antimicrobial resistance in Sweden. 2012. 2012.
  • Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010; 54: 3564–8. [PubMed Abstract] [PubMed CentralFull Text].
  • Lausch KR, Fuursted K, Larsen CS, Storgaard M. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study. Travel Med Infect Dis. 2013; 11: 320–3. [PubMed Abstract].
  • March A, Aschbacher R, Pagani E, Sleghel F, Soelva G, Hopkins KL, etal. Changes in colonization of residents and staff of a long-term care facility and an adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year period. Scand J Infect Dis. 2014; 46: 114–22. [PubMed Abstract].
  • Jadhav S, Sahasrabudhe T, Kalley V, Gandham N. The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study. J Clin Diagn Res. 2013; 7: 1021–6. [PubMed Abstract] [PubMed CentralFull Text].
  • Deege MP, Paterson DL. Reducing the development of antibiotic resistance in critical care units. Curr Pharm Biotechnol. 2011; 12: 2062–9. [PubMed Abstract].
  • Trott D. β-Lactam resistance in gram-negative pathogens isolated from animals. Curr Pharm Des. 2013; 19: 239–49. [PubMed Abstract].
  • Reuland EA, Al Naiemi N, Raadsen SA, Savelkoul PH, Kluytmans JA, Vandenbroucke-Grauls CM. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur J Clin Microbiol Infect Dis. 2014. [Epub ahead of print].
  • Egervarn M, Borjesson S, Byfors S, Finn M, Kaipe C, Englund S, etal. Escherichia coli with extended-spectrum beta-lactamases or transferable AmpC beta-lactamases and Salmonella on meat imported into Sweden. Int J Food Microbiol. 2014; 171: 8–14. [PubMed Abstract].
  • Tschudin-Sutter S, Frei R, Stephan R, Hachler H, Nogarth D, Widmer AF. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: a threat from the kitchen. Infect Control Hosp Epidemiol. 2014; 35: 581–4. [PubMed Abstract].
  • Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. Scand J Infect Dis. 2012; 44: 51–4. [PubMed Abstract].
  • Lohr IH, Rettedal S, Natas OB, Naseer U, Oymar K, Sundsfjord A. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother. 2013; 68: 1043–8. [PubMed Abstract].
  • Tham J, Walder M, Melander E, Odenholt I. Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scand J Infect Dis. 2012; 44: 573–7. [PubMed Abstract].
  • Titelman E, Hasan CM, Iversen A, Naucler P, Kais M, Kalin M. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect. 2014. [Epub ahead of print].
  • Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008; 46: 2796–9. [PubMed Abstract] [PubMed CentralFull Text].
  • Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008; 62: 1142–9. [PubMed Abstract].
  • Lo WU, Ho PL, Chow KH, Lai EL, Yeung F, Chiu SS. Fecal carriage of CTXM type extended-spectrum beta-lactamase-producing organisms by children and their household contacts. J Infect. 2010; 60: 286–92. [PubMed Abstract].
  • Tande D, Boisrame-Gastrin S, Munck MR, Hery-Arnaud G, Gouriou S, Jallot N, etal. Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children. J Antimicrob Chemother. 2010; 65: 859–65. [PubMed Abstract].
  • Cottell JL, Webber MA, Piddock LJ. Persistence of transferable extended-spectrum-beta-lactamase resistance in the absence of antibiotic pressure. Antimicrob Agents Chemother. 2012; 56: 4703–6. [PubMed Abstract] [PubMed CentralFull Text].